Source:http://linkedlifedata.com/resource/pubmed/id/11679164
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-10-26
|
pubmed:abstractText |
DNA replication proteins represent a class of extremely well-established anti-infective drug targets for which improvements in assay technology are required in order to support enzyme characterization, HTS, and structure-activity relationship studies. Replication proteins are conventionally assayed using precipitation/filtration or gel-based techniques, and are not yet all suitable for conversion into homogeneous fluorescence-based formats. We have therefore developed radiometric assays for these enzymes based upon FlashPlate technology that can be applied to a wide range of targets using a common set of reagents. This approach has allowed the rapid characterization of DNA polymerase, DNA primase, and DNA helicase activities. The resultant 96-/384-well microplate assays are suitable for primary HTS, hit selectivity determination, and/or elucidating the mechanism of action of inhibitors. In all cases, biotinylated DNA oligonucleotide substrates were tethered to streptavidin-coated scintillant-embedded FlashPlate wells. Various adaptations were employed for each enzyme activity. For DNA polymerase, a short complementary oligonucleotide primer was annealed to the longer tethered oligonucleotide, and polymerization was measured by incorporation of [(3)H]-dNTPs onto the growing primer 3' end. For DNA primase, direct synthesis of short oligoribonucleotides complementary to the tethered DNA strand was measured by incorporation of [(3)H]-rNTPs or by subsequent polymerase extension with [(3)H]-dNTPs from unlabeled primers. For DNA helicase, unwinding of a [(33)P]-labeled oligonucleotide complementary to the tethered oligonucleotide was measured. This robust and flexible system has a number of substantial advantages over conventional assay techniques for this difficult class of enzymes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1087-0571
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-46
|
pubmed:dateRevised |
2011-5-23
|
pubmed:meshHeading |
pubmed-meshheading:11679164-DNA Helicases,
pubmed-meshheading:11679164-DNA Primase,
pubmed-meshheading:11679164-DNA-Directed DNA Polymerase,
pubmed-meshheading:11679164-Drug Evaluation, Preclinical,
pubmed-meshheading:11679164-Escherichia coli,
pubmed-meshheading:11679164-Herpesvirus 1, Human,
pubmed-meshheading:11679164-Oligodeoxyribonucleotides,
pubmed-meshheading:11679164-Radioligand Assay,
pubmed-meshheading:11679164-Scintillation Counting,
pubmed-meshheading:11679164-Simian virus 40,
pubmed-meshheading:11679164-Substrate Specificity
|
pubmed:year |
2001
|
pubmed:articleTitle |
FlashPlate scintillation proximity assays for characterization and screening of DNA polymerase, primase, and helicase activities.
|
pubmed:affiliation |
Molecular Interactions and New Assay Technologies, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Essex, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|